Browsing byAuthorLuk, F

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 24  next >
Issue DateTitleAuthor(s)
2013-04-12Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to CellsJaiswal, R; Luk, F; Dalla, PV; Grau, GER; Bebawy, M
2013-12-17Cell-derived microparticles: New targets in the therapeutic management of diseaseRoseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M
2013-10-01Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21<sup>st</sup> centuryLee, WH; Loo, CY; Bebawy, M; Luk, F; Mason, RS; Rohanizadeh, R
2015-01-01Fabrication of curcumin micellar nanoparticles with enhanced anti-cancer activityLee, WH; Bebawy, M; Loo, CY; Luk, F; Mason, RS; Rohanizadeh, R
2015-02-15Functional translation of total RNA packaged in microparticles shed from multidrug resistant cancer cellsLu, JF; Pokharel, D; Luk, F; Bebawy, M
2014-01-01Inhibition of the multidrug resistance P-glycoprotein: Time for a change of strategy?Callaghan, R; Luk, F; Bebawy, M
2016-01-01Isolation of Human CD138<sup>+</sup> Microparticles from the Plasma of Patients with Multiple MyelomaKrishnan, SR; Luk, F; Brown, RD; Suen, H; Kwan, Y; Bebawy, M
2012-01Microparticle Conferred MicroRNA Profiles - Implications In The Transfer And Dominance Of Cancer TraitsJaiswal, R; Luk, F; Gong, J; Mathys, J; Grau, G; Bebawy, M
2012-06-08Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traitsJaiswal, R; Luk, F; Gong, J; Mathys, JM; Grau, GER; Bebawy, M
2012-01Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.Jaiswal, R; Luk, F; Gong, J; Mathys, J-M; Grau, GER; Bebawy, M
2013-01Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistanceGong, J; Luk, F; Jaiswal, R; George, AM; Grau, G; Bebawy, M
2013-12-05Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistanceGong, J; Luk, F; Jaiswal, R; George, AM; Grau, GER; Bebawy, M
2015-08-01Microparticles as novel prognostic markers in multiple myelomaRajeev Krishnan, S; Bebawy, M; Brown, RD; Luk, F; Kwan, Y
2015-02-15Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancerGong, J; Luk, F; Jaiswal, R; Bebawy, M
2015-04Microparticles in cancer: A review of recent developments and the potential for clinical applicationGong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M
2015-04-01Microparticles in cancer: A review of recent developments and the potential for clinical applicationGong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M
2013-09-02Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathwaysLu, JF; Luk, F; Gong, J; Jaiswal, R; Grau, GER; Bebawy, M
2014-01-01Microparticles mediate the intercellular regulation of microRNA-503 and proline-rich tyrosine kinase 2 to alter the migration and invasion capacity of breast cancer cellsGong, J; Luk, F; Jaiswal, R; Bebawy, M
2016-07-01Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review)Krishnan, SR; Jaiswal, R; Brown, RD; Luk, F; Bebawy, M
2015-09-01Multiple myeloma: A novel tailor-made therapeutic management.Krishnan, SR; Bebawy, M; Luk, F; Brown, RD; Kwan, YL